1 November 2024 ANNA.MONEY Software false true true true false No description of principal activity 0 0 true xbrli:pure xbrli:shares iso4217:GBP SC786772 2024-11-01 2025-10-31 SC786772 2023-10-23 2024-10-31 SC786772 2025-10-31 SC786772 2024-10-31 SC786772 core:WithinOneYear 2025-10-31 SC786772 core:WithinOneYear 2024-10-31 SC786772 bus:RegisteredOffice 2024-11-01 2025-10-31 SC786772 bus:Director1 2024-11-01 2025-10-31 SC786772 1 2024-11-01 2025-10-31 SC786772 countries:Scotland 2024-11-01 2025-10-31 SC786772 bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 SC786772 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 SC786772 bus:Micro-entities 2024-11-01 2025-10-31 SC786772 bus:FullAccounts 2024-11-01 2025-10-31
Company registration number:
SC786772
DELTON THERAPY LIMITED
Unaudited Filleted Financial Statements for the year ended
31 October 2025
DELTON THERAPY LIMITED
Statement of Financial Position
31 October 2025
2025 2024
£ £
Fixed assets 553 665
Current assets 4,515 8,361
Prepayments and accrued income 15 -
Creditors: amounts falling due within one year (1,554 ) (3,237 )
Net current assets 2,976 5,124
Total assets less current liabilities 3,529 5,789
Accruals and deferred income (45 ) -
Total net assets 3,484 5,789
Capital and reserves 3,484 5,789

Notes to the Financial Statements

1 General information

The company is a private company limited by shares and is registered in Scotland. The address of the registered office is Flat M/2, 95 Spean Street, Glasgow, G44 4FA, Scotland.

2 Average number of employees

The average number of persons employed by the company during the year was Nil (2024: Nil).
For the year ending 31 October 2025, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 8 July 2026, and are signed on behalf of the board by:
L. Wyllie
Director
Company registration number: SC786772